With the identification of H3R antagonizing properties of A-366, our in vitro characterization presents this compound as a multi-target ligand that has a high potential to show symptomatic effects in the neurogenetic PWS, congruent to those described for pitolisant (Fig. 3). The gene discussed is HRH3; the disease is Prader-Willi syndrome.